Cargando…

The Prevalence and Determinants of Hepatic Steatosis Assessed by Controlled Attenuation Parameter in Thai Chronic Hepatitis C Patients

AIMS: To describe the prevalence of hepatic steatosis using a controlled attenuation parameter (CAP) and to identify the determinants associated with steatosis in Thai chronic hepatitis C patients. Patients and Methods. An observational study was conducted among consecutive chronic hepatitis C patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sirinawasatien, A., Techasirioangkun, T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655258/ https://www.ncbi.nlm.nih.gov/pubmed/33204256 http://dx.doi.org/10.1155/2020/8814135

Ejemplares similares

Prevalence and Determinants of Significant Liver Fibrosis by Vibration-Controlled Transient Elastography in Thai Chronic Hepatitis B Patients
por: Sirinawasatien, Apichet, et al.
Publicado: (2018)

Sofosbuvir-based regimens in the treatment of patients with chronic hepatitis C virus infection: Real-world efficacy in Thailand
por: Sirinawasatien, Apichet, et al.
Publicado: (2020)

Accuracy of attenuation imaging in the assessment of pediatric hepatic steatosis: correlation with the controlled attenuation parameter
por: Kim, Pyeong Hwa, et al.
Publicado: (2022)

Validating controlled attenuation parameter in the assessment of hepatic steatosis in living liver donors
por: Broering, Dieter, et al.
Publicado: (2021)

Evaluation of controlled attenuation parameter in assessing hepatic steatosis in patients with autoimmune liver diseases
por: Ni, Xi-Xi, et al.
Publicado: (2021)

Factors Affecting the Accuracy of Controlled Attenuation Parameter (CAP) in Assessing Hepatic Steatosis in Patients with Chronic Liver Disease
por: Jung, Kyu Sik, et al.
Publicado: (2014)

Eradication of hepatitis C virus is associated with the attenuation of steatosis as evaluated using a controlled attenuation parameter
por: Shimizu, Kohei, et al.
Publicado: (2018)

Prevalence of hepatic steatosis and associated factors in Iranian patients with chronic hepatitis C
por: Poortahmasebi, Vahdat, et al.
Publicado: (2016)

Correction: Factors Affecting the Accuracy of Controlled Attenuation Parameter (CAP) in Assessing Hepatic Steatosis in Patients with Chronic Liver Disease
Publicado: (2014)

The relationship between visceral obesity and hepatic steatosis measured by controlled attenuation parameter
por: Lee, Hye Won, et al.
Publicado: (2017)

Quick assessment with controlled attenuation parameter for hepatic steatosis in children based on MRI-PDFF as the gold standard
por: Shin, Jaeseung, et al.
Publicado: (2019)

Similar prevalence of hepatic steatosis among patients with chronic hepatitis C with and without HIV coinfection
por: Fernandez-Fuertes, M., et al.
Publicado: (2020)

Morphometric Analysis of Hepatic Steatosis in Chronic Hepatitis C Infection
por: Zubair, Alia, et al.
Publicado: (2009)

Relationship between Controlled Attenuation Parameter and Hepatic Steatosis as Assessed by Ultrasound in Alcoholic or Nonalcoholic Fatty Liver Disease
por: Ahn, Jem Ma, et al.
Publicado: (2016)

Diagnostic and prognostic significance of hepatic steatosis in patients with chronic hepatitis C
por: Stan, Ionelia Sorina, et al.
Publicado: (2021)

PNPLA3 genetic variants determine hepatic steatosis in non-obese chronic hepatitis C patients
por: Huang, Chung-Feng, et al.
Publicado: (2015)

Steatosis and hepatitis C
por: Modaresi Esfeh, Jamak, et al.
Publicado: (2016)

Non-Invasive Assessment of Hepatic Steatosis in Patients with NAFLD Using Controlled Attenuation Parameter and (1)H-MR Spectroscopy
por: Karlas, Thomas, et al.
Publicado: (2014)

Prevalence of hepatic steatosis as assessed by controlled attenuation parameter (CAP) in subjects with metabolic risk factors in primary care. A population-based study
por: Fabrellas, Núria, et al.
Publicado: (2018)

Feasibility of Ultrasound Attenuation Imaging for Assessing Pediatric Hepatic Steatosis
por: Song, Kyungchul, et al.
Publicado: (2022)

Noninvasive assessment of paediatric hepatic steatosis by using attenuation imaging
por: Hwang, Sook Min, et al.
Publicado: (2023)

Accuracy of controlled attenuation parameter compared with ultrasound for detecting hepatic steatosis in children with severe obesity
por: Runge, Jurgen H., et al.
Publicado: (2020)

Reproducibility of ultrasound-guided attenuation parameter (UGAP) to the noninvasive evaluation of hepatic steatosis
por: Zhao, Yanan, et al.
Publicado: (2022)

Short-Term Hypocaloric High-Fiber and High-Protein Diet Improves Hepatic Steatosis Assessed by Controlled Attenuation Parameter
por: Arslanow, Anita, et al.
Publicado: (2016)

Quantitative ultrasound radiofrequency data analysis for the assessment of hepatic steatosis using the controlled attenuation parameter as a reference standard
por: Jeon, Sun Kyung, et al.
Publicado: (2021)

Diagnostic Accuracy of Non-Imaging and Ultrasound-Based Assessment of Hepatic Steatosis Using Controlled Attenuation Parameter (CAP) as Reference
por: Kozłowska-Petriczko, Katarzyna, et al.
Publicado: (2021)

Computed Tomography Measurement of Hepatic Steatosis: Prevalence of Hepatic Steatosis in a Canadian Population
por: Wells, Malcolm M., et al.
Publicado: (2016)

Association of serum uric acid with hepatic steatosis detected by controlled attenuation parameter in the United States population
por: Feng, Yunfu, et al.
Publicado: (2023)

Hepatic steatosis is highly prevalent but is not correlated with stiffness in autoimmune hepatitis
por: Chalasani, Sai, et al.
Publicado: (2020)

Assessment of Predictive Factors of Hepatic Steatosis Diagnosed by Vibration Controlled Transient Elastography (VCTE) in Chronic Hepatitis C Virus-Infected Patients
por: Singh, Yuvaraj, et al.
Publicado: (2022)

Hepatitis C Virus (HCV) Infection and Hepatic Steatosis
por: Yoon, Eugene J., et al.
Publicado: (2006)

Naringenin attenuates hepatitis B virus X protein-induced hepatic steatosis
por: Lin, Hung-Jen, et al.
Publicado: (2017)

Current treatment for hepatitis C virus/human immunodeficiency virus coinfection in adults
por: Laiwatthanapaisan, Ratchapong, et al.
Publicado: (2021)

Liver steatosis in children with chronic hepatitis B and C: Prevalence, predictors, and impact on disease progression
por: Pokorska-Śpiewak, Maria, et al.
Publicado: (2017)

A noninvasive diagnostic model to assess nonalcoholic hepatic steatosis in patients with chronic hepatitis B
por: Ou, Hongjie, et al.
Publicado: (2016)

Hepatocellular carcinoma in patients cured of chronic hepatitis C: Minimal steatosis
por: Rocha, Chiara, et al.
Publicado: (2023)

Clinical and Virological Characteristics of Chronic Hepatitis B Patients with Hepatic Steatosis
por: Zheng, Rui-dan, et al.
Publicado: (2013)

Lipid accumulation product independently correlate with hepatic steatosis quantified by controlled attenuation parameter in women with polycystic ovary syndrome
por: Zheng, Silan, et al.
Publicado: (2020)

IL-33 treatment attenuated diet-induced hepatic steatosis but aggravated hepatic fibrosis
por: Gao, Yinjie, et al.
Publicado: (2016)

Impact of PNPLA3 and IFNL3 polymorphisms on hepatic steatosis in Asian patients with chronic hepatitis C
por: Huang, Chao-Min, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_94nluqtdv372oc5jh2ue7eckfk